Blog
RSS FeedPosted by Michael Wonder on 03 Mar 2025
TGA decides not to register lecanemab in Australia
3 March 2025 - BioArctic's partner Eisai announced today that the TGA has declined the approval of lecanemab as a treatment ...
Posted by Michael Wonder on 06 Sep 2022
NASWSI and Project Orbis - are they essentially the same?
7 September 2022 - We compare and contrast the two initiatives to bring new medicines to the market faster. ...
Posted by Michael Wonder on 27 Jul 2022
MS Health push for nurses to hand out abortion pills
27 July 2022 - Nurses and midwives would prescribe medical abortion pills under a push by the company that imports ...
Posted by Michael Wonder on 30 Mar 2021
Terminal cancer patients denied new treatments due to slow TGA approval
31 March 2021 - Desperate cancer patients are begging Australia’s drugs regulator to save lives by speeding up approvals and cutting ...
Posted by Michael Wonder on 15 Mar 2018
Product withdrawn after overseas reports of inflammatory brain disorders
15 March 2018 - Consumers and health professionals are advised that Biogen Australia, in consultation with the TGA, will withdraw ...
Posted by Michael Wonder on 13 Jan 2016
Registration of new chemical entities in Australia in 2015
5 January 2016 - Each year, approximately 40 new prescription medicines containing new active substances are registered. ...
Posted by Michael Wonder on 24 Sep 2015
TGA publishes another 6 AusPARs
25 September 2015 - The TGA has published another six AusPARs. ...
Posted by Michael Wonder on 17 Sep 2015
TGA devices sponsor information day 2015
17 September 2015 - Sponsors, agents and manufacturers of medical devices and in-vitro diagnostic medical devices are invited to attend a ...